Document Detail

Blood-brain barrier integrity in a zolpidem-responder patient.
MedLine Citation:
PMID:  23034205     Owner:  NLM     Status:  MEDLINE    
A 27-year-old neurologically disabled but fully conscious male zolpidem-responder patient was investigated for blood brain barrier (BBB) dysfunction 5 years after a traumatic brain injury. A baseline single-photon emission computed tomography (SPECT) technetium-99m-labelled hexamethylpropylene amine oxime (99mTcHMPAO) brain scan was performed and the patient was administered 10 mg zolpidem daily. The patient was rescanned 2 weeks later when 99mTcHMPAO was injected 1 hour after zolpidem application. SPECT technetium-99m-labelled diethylene-triamine-pentacetic acid (99mTcDTPA) BBB scans were also performed before and after zolpidem treatment. There was decreased uptake of 99mTcHMPAO in the left frontoparietal brain region, left temporal region and left thalamus on baseline scanning; this improved within 1 hour after zolpidem treatment at the follow-up scan. The 99mTcDTPA scan remained within normal limits before and after zolpidem treatment. The patient's neurological disabilities, especially coordination, speech and gait, improved markedly. The Barthel Index remained normal, but the Tinetti falls efficacy scale improved from 21/100 to 15/100. The results implied that the underlying cause for the patient's long-term neurological disability and brain suppression was not due to a long-term dysfunctional BBB.
N E Nyakale; R P Clauss; H W Nel; M M Sathekge
Related Documents :
17361245 - Latanoprost versus timolol gel-forming solution once daily in primary open-angle glauco...
1543395 - Postoperative electromyographic profile in human jejunum.
12598435 - Screening for primary angle closure in mongolia: a randomised controlled trial to deter...
24708175 - Postural stability disorders in patients with osteoarthritis of the hip.
2692485 - Clinical and pathologic effects of spiral and total ring prostheses applied to the cerv...
23832495 - The long-term outcome of nerve combing for trigeminal neuralgia.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2012-07-31
Journal Detail:
Title:  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde     Volume:  102     ISSN:  0256-9574     ISO Abbreviation:  S. Afr. Med. J.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-04     Completed Date:  2012-12-04     Revised Date:  2014-09-12    
Medline Journal Info:
Nlm Unique ID:  0404520     Medline TA:  S Afr Med J     Country:  South Africa    
Other Details:
Languages:  eng     Pagination:  790-1     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood-Brain Barrier / physiopathology*,  radionuclide imaging
Brain Injuries / drug therapy*,  physiopathology*,  radionuclide imaging
GABA-A Receptor Agonists / therapeutic use*
Pyridines / therapeutic use*
Tomography, Emission-Computed, Single-Photon
Reg. No./Substance:
0/GABA-A Receptor Agonists; 0/Pyridines; 7K383OQI23/zolpidem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Unforeseen ethical/legal complications with screening tests in the capitation model of medical aid s...
Next Document:  Introducing a national health insurance system in South Africa: a general practitioner's bottom-up a...